You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
复星医药(02196.HK)复宏汉霖拟发行境外上市外资股获证监会核准
格隆汇 07-12 16:32

格隆汇7月12日丨复星医药(02196.HK)发布公告,复宏汉霖于近日收到中国证监会《关于核准上海复宏汉霖生物技术股份有限公司发行境外上市外资股的批复》(证监许可[2019]1222号),批复如下:

1、核准复宏汉霖新发行不超过96,282,002股境外上市外资股,每股面值人民币1元,全部为普通股。完成本次发行后,复宏汉霖可到香港联交所主板上市。

2、核准复宏汉霖完成本次发行后,HenliusBiopharmaceuticalsInc.等13名复宏汉霖股东持有的合计94,366,741股存量股份转为境外上市外资股。在符合境内外有关法律、法规和规则的情况下,上述股东可将所持股份在香港联交所主板流通。

3、上市后15个工作日内,复宏汉霖应将非境外上市股份集中登记存管在中国证券登记结算有限责任公司,并将股份集中登记存管及本次发行上市的情况书面报告中国证监会。

4、复宏汉霖在境外发行股票和上市过程中,应严格遵守境内外有关法律、法规和规则。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account